These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 26289791)
1. Novel chemotherapeutics and other therapies for treating high-grade glioma. Kang JH; Adamson C Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791 [TBL] [Abstract][Full Text] [Related]
2. Investigational new drugs for brain cancer. Staedtke V; Bai RY; Laterra J Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era. Uhm JH; Porter AB Mayo Clin Proc; 2017 Jun; 92(6):995-1004. PubMed ID: 28578786 [TBL] [Abstract][Full Text] [Related]
4. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens. Batich KA; Sampson JH Expert Opin Pharmacother; 2014 Oct; 15(14):2047-61. PubMed ID: 25139628 [TBL] [Abstract][Full Text] [Related]
5. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
6. Novel approaches to glioma drug design and drug screening. Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794 [TBL] [Abstract][Full Text] [Related]
7. Emerging patents in the therapeutic areas of glioma and glioblastoma. Harris M; Svensson F; Kopanitsa L; Ladds G; Bailey D Expert Opin Ther Pat; 2018 Jul; 28(7):573-590. PubMed ID: 29950117 [TBL] [Abstract][Full Text] [Related]
9. Malignant Intracranial High Grade Glioma and Current Treatment Strategy. Zhang X; Zhang W; Mao XG; Cao WD; Zhen HN; Hu SJ Curr Cancer Drug Targets; 2019; 19(2):101-108. PubMed ID: 29848277 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for glioma: from illusion to realistic prospects? Dietrich PY; Dutoit V; Walker PR Am Soc Clin Oncol Educ Book; 2014; ():51-9. PubMed ID: 24857060 [TBL] [Abstract][Full Text] [Related]
17. Novel therapeutics for brain tumors: current practice and future prospects. El Demerdash N; Kedda J; Ram N; Brem H; Tyler B Expert Opin Drug Deliv; 2020 Jan; 17(1):9-21. PubMed ID: 31971041 [No Abstract] [Full Text] [Related]
18. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122 [TBL] [Abstract][Full Text] [Related]
19. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma. Sonabend AM; Dana K; Lesniak MS Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318 [TBL] [Abstract][Full Text] [Related]
20. Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins. Loya J; Zhang C; Cox E; Achrol AS; Kesari S CNS Oncol; 2019 Nov; 8(3):CNS38. PubMed ID: 31747788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]